Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Macrogen obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT' 2020-05-21 10:03
Marketing Authorization Application for Luye Pharma's Rivastigmine Multi-Day Transdermal Patch Product Rivalif® under Review at EU Competent Authorities 2020-05-20 19:34
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models 2020-05-20 19:00
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia 2020-05-19 19:00
Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections 2020-05-19 09:45
Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers 2020-05-19 07:30
Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting 2020-05-15 12:01
Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting 2020-05-15 12:01
Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen 2020-05-15 11:52
Innovent Announces Key Results from a Number of Clinical Studies to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting 2020-05-15 07:30
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R) (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment 2020-05-14 19:00
Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) 2020-05-14 09:26
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-05-14 07:30
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 2020-05-14 06:46
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19 2020-05-14 01:56
Ascletis' THR- beta Agonist ASC41 Receives Approval for Clinical Trials of NASH Indication 2020-05-13 18:30
Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment 2020-05-13 17:51
QPS Announces Novel Coronavirus/COVID-19 Testing Capability 2020-05-12 19:11
Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology 2020-05-11 21:00
Technopath Clinical Diagnostics Expands Its Portfolio of Third-party Quality Control Solutions for COVID-19 as Clinical Laboratories Globally Ramp Up Antibody Testing 2020-05-11 14:00
1 179 180 181 182 183 253